Hyperlipidemia and fatty infiltration of the liver are characteristics of chronic alcohol abuse these pathological manifestations are due to 1. increased VLDL synthesis 2. defective catabolism of triglyceride-rich (TGR) lipoproteins both in the liver and peripheral tissues. 3. Production of abnormal remnants which show defective feed-back regulation of hepatic lipid synthesis 4. impaired binding and uptake of remnants by the liver and 5. defective hepatic catabolism of the lipid moieties of the remnants recently, W-3 fatty acid feeding has been shown to be very effective in the treatment of genetic hyperlipidemia such as type IIB and type V by lowering plasma lipids. The possible mechanisms of action of W-3 fatty acids are to cause (A) decreased synthesis of VLDL and chylomicrons and (B) increased rates of degradation of VLDL and chylomicrons. Thus, the actions of W-3 fatty acids seen to be just the opposite of those of ethanol abuse. Therefore, it would be pertinent and clinically relevant to test whether W-3 fatty acid feeding would reverse many of the adverse effects of alcohol abuse on lipid and lipoprotein metabolism using the rat as the animal model. The present proposal seeks to explore not only the hypolipidemic effects of W-3 fatty acid but also their possible mechanisms of action with respect to alcoholic hyperlipidemia by answering the following key questions: 1a. Does the isocaloric replacement of normal dietary fat with fish oils prevent the development of fatty liver and hyperlipidemia associated with chronic ethanol feeding? 1b. How do these results correlate with the effects of fish oil in control rats? 2. Conversely, can the ethanol induced fatty liver and hyperlipidemia be restored to normolipidemic state by fish oils? 3. Does W-3 fatty acid feeding affect the rate of production of chylomicrons in chronic ethanol-fed & control rats? 4. How does W-3 fatty acid feeding affect the extra-hepatic metabolism of TGR lipoproteins in chronic ethanol-fed control rats? 5. How does W- 3 fatty acid feeding affect the hepatic metabolism of TGR lipoproteins in chronic ethanol-fed & control rats? 6. Does the feeding of W-3 fatty acids alter the normal feed-back regulation of hepatic lipid synthesis by chylomicron remnants in chronic ethanol-fed & control rats? The following experimental systems and procedures, in which the PI has expertise, will be employed to accomplish the above goals and objectives: A. in vivo systems involving cannulate of the thoracic duct, jugular vein, carotid artery, and other techniques described in proposal. B. In vitro systems such as perfused liver, perfused heart, and hepatocytes. C. Polyacrylamide gel electrophoresis. D. tracer techniques, and E. Immunonephelometry.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA008149-02
Application #
3112112
Study Section
Alcohol Biomedical Research Review Committee (ALCB)
Project Start
1988-09-30
Project End
1992-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
George Washington University
Department
Type
Schools of Medicine
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20052
Gong, Maokai; Castillo, Leslie; Redman, Robert S et al. (2008) Down-regulation of liver Galbeta1, 4GlcNAc alpha2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans. Metabolism 57:1663-8
Gong, Maokai; Garige, Mamatha; Hirsch, Kenneth et al. (2007) Liver Galbeta1,4GlcNAc alpha2,6-sialyltransferase is down-regulated in human alcoholics: possible cause for the appearance of asialoconjugates. Metabolism 56:1241-7
Marmillot, Philippe; Patel, Sanket; Lakshman, M Raj (2007) Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins. Metabolism 56:251-9
Marmillot, Philippe; Munoz, Jennifer; Patel, Sanket et al. (2007) Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans. Metabolism 56:947-53
Azuine, Magnus A; Patel, Sanket J; Lakshman, M Raj (2006) Effects of chronic ethanol administration on the activities and relative synthetic rates of myelin and synaptosomal plasma membrane-associated sialidase in the rat brain. Neurochem Int 48:67-74
Garige, Mamatha; Azuine, Magnus A; Lakshman, M Raj (2006) Chronic ethanol consumption down-regulates CMP-NeuAc:GM3 alpha 2,8-sialyltransferase (ST8Sia-1) gene in the rat brain. Neurochem Int 49:312-8
Garige, Mamatha; Gong, Maokai; Lakshman, M Raj (2006) Ethanol destabilizes liver Gal beta l, 4GlcNAc alpha2,6-sialyltransferase, mRNA by depleting a 3'-untranslated region-specific binding protein. J Pharmacol Exp Ther 318:1076-82
Garige, Mamatha; Azuine, Magnus A; Lakshman, M Raj (2006) Chronic ethanol consumption upregulates the cytosolic and plasma membrane sialidase genes, but down regulates lysosomal membrane sialidase gene in rat liver. Metabolism 55:803-10
Azuine, Magnus A; Patel, Sanket J; Lakshman, M Raj (2005) Chronic ethanol feeding controls the activities of various sialidases by regulating their relative synthetic rates in the rat liver. Metabolism 54:1056-64
Garige, Mamatha; Gong, Maokai; Rao, Manjunath N et al. (2005) Mechanism of action of ethanol in the down-regulation of Gal(beta)1, 4GlcNAc alpha2,6-sialyltransferase messenger RNA in human liver cell lines. Metabolism 54:729-34

Showing the most recent 10 out of 18 publications